Inovio Pharmaceuticals (INO) Receivables - Other (2010 - 2023)
Inovio Pharmaceuticals (INO) reported Receivables - Other of $4.96 million for Q1 2023, up 41.8% from $3.5 million a year earlier but down 49.9% from the prior quarter.
Powered by 
Analysis
Inovio Pharmaceuticals (INO) Receivables - Other (2010 - 2023) Analysis & Trends
At the end of FY2022, Inovio Pharmaceuticals posted Receivables - Other of $10.04 million, up 178.8% from FY2021.
- Receivables - Other has a five-year compound annual growth rate of 83.2% (FY2017 to FY2022).
- By year, Receivables - Other came in at $3.6 million in FY2021 (+614.6%), $503,782 in FY2020 (-62.2%), $1.33 million in FY2019 (+80.4%) and $738,583 in FY2018 (+51.8%).
- Five-year quarterly Receivables - Other spans a low of $492,000 in Q4 2020 and a high of $12.9 million in Q2 2021.
- Year over year, Receivables - Other has now increased in each of the last three quarters, with growth averaging 142.8% over the last eight quarters.
- The high point for year-over-year Receivables - Other in five years was Q3 2020 (growth of 686.9%); the low point was Q3 2021 (a decline of 69.4%).
- Per Business Quant data, the three quarters before Q1 2023 came in at $9.9 million (Q4 2022), $7.64 million (Q3 2022) and $6.89 million (Q2 2022).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn |
| 10 | Inovio Pharmaceuticals | 68.68 Mn | -114.99 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2023 | 4.96 Mn |
| Dec 31, 2022 | 9.90 Mn |
| Sep 30, 2022 | 7.64 Mn |
| Jun 30, 2022 | 6.89 Mn |
| Mar 31, 2022 | 3.50 Mn |
| Dec 31, 2021 | 2.63 Mn |
| Sep 30, 2021 | 2.35 Mn |
| Jun 30, 2021 | 12.90 Mn |
| Mar 31, 2021 | 9.60 Mn |
| Dec 31, 2020 | 492,000.00 |
| Sep 30, 2020 | 7.70 Mn |
| Jun 30, 2020 | 2.90 Mn |
| Mar 31, 2020 | 634,198.00 |
| Dec 31, 2019 | 616,000.00 |
| Sep 30, 2019 | 978,544.00 |
| Jun 30, 2019 | 996,936.00 |
| Mar 31, 2019 | 1.30 Mn |
| Dec 31, 2018 | 736,000.00 |
| Sep 30, 2018 | 1.57 Mn |
| Jun 30, 2018 | 960,453.00 |
API Access
Inovio Pharmaceuticals Receivables - Other API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-other&ticker=INO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-other", "ticker": "INO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables-other&ticker=INO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();